These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1999848)

  • 21. [The physiological function of human endometrium].
    Watanabe J; Hata H; Masuda K; Kuramoto H
    Hum Cell; 1991 Sep; 4(3):230-6. PubMed ID: 1782183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism of action of endocrine therapy of endometrial carcinoma].
    Kuramoto H; Hata H; Kato Y; Hata K; Hamano M; Anzai Y; Watanabe J; Holinka CF; Gurpide E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1851-7. PubMed ID: 2730078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.
    Raspollini MR; Mecacci F; Paglierani M; Marchionni M; Taddei GL
    Pathol Res Pract; 2005; 201(2):141-4. PubMed ID: 15901136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages.
    Myers MJ; Ghildyal N; Schook LB
    Immunology; 1995 Jun; 85(2):318-24. PubMed ID: 7642223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice.
    Kimura J
    Cancer Res; 1978 Jan; 38(1):78-82. PubMed ID: 618585
    [No Abstract]   [Full Text] [Related]  

  • 28. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
    Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
    Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological findings and prognosis from uterine malignancy.
    Hernandez E
    Curr Opin Obstet Gynecol; 1993 Aug; 5(4):480-5. PubMed ID: 8400044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of progesterone on human endometrial carcinoma cells in vivo and in vitro.
    Ishiwata I; Udagawa Y; Okumura H; Nozawa S
    J Natl Cancer Inst; 1978 May; 60(5):947-54. PubMed ID: 642036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells.
    Suzuki T; Takimoto K
    Int J Oncol; 2004 Jul; 25(1):153-9. PubMed ID: 15202000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro.
    Steller MA; Mok SC; Yeh J; Fulop V; Anderson DJ; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):209-16. PubMed ID: 8035376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of endometrial hyperplasia].
    Tanaka K; Yasuda M; Motizuki M; Sasaki T; Yamazaki T; Kurose T; Sasagawa M; Hando T; Ohmori M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1598-604. PubMed ID: 2525003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medrogestone therapy in advanced endometrial adenocarcinoma.
    Waterman EA; Benson RC
    Obstet Gynecol; 1967 Nov; 30(5):626-34. PubMed ID: 4167865
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
    Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of the antitumor action of gestagens on endometrial cancer].
    Nishida M; Kasahara K; Tsuji T; Kaneko M; Iwasaki H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2214-22. PubMed ID: 3805831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.
    Kacinski BM; Carter D; Kohorn EI; Mittal K; Bloodgood RS; Donahue J; Kramer CA; Fischer D; Edwards R; Chambers SK
    Yale J Biol Med; 1989; 62(4):379-92. PubMed ID: 2556864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
    Jovanovic AS; Boynton KA; Mutter GL
    Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.